News

Small Lymphocytic Lymphoma Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2025 | DelveInsight
DelveInsight’s, “ Small Lymphocytic Lymphoma Pipeline Insight, 2025 ” report provides comprehensive insights about 80+ ...
European Medical Journal4d
ICML 2025: Blood Test Shows Promise for Tracking Lymphoma Relapse Risk
Real-world data presented at the 2025 International Conference on Malignant Lymphoma (ICML) has provided new insights into the use of clonoSEQ, a circulating tumour DNA (ctDNA) ...
The American Journal of Managed Care3d
Real-World Study Finds Brentuximab Vedotin With Chemo Is Safe, Effective in First-line Treatment of PTCL
Brentuximab vedotin combined with cyclophosphamide, doxorubicin, and prednisone (CHP) shows promising results as a first-line ...
Oncology Nurse Advisor2d
Leveraging NK Cell Subtypes Improves Understanding of CLL Progression
A distinct natural killer (NK) cell subset, termed CLL_NK, is a precursor to effector NK phenotypes and serves as a critical immunologic marker in chronic lymphocytic leukemia (CLL), offering ...
HotCopper on MSN6d
This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution
It’s no secret that the rate of cancer both in Australia and overseas appears to be increasing – particularly among young ...